• New Drug Combination Could be More Effective Against Melanoma

    Share Now7sharesFacebook7Twitter0Google+Pinterest0New Drug Combination Could be More Effective Against Melanoma By: Anne Trafton | MIT News Office A class of cancer drugs called protein kinase inhibitors is one of the most effective treatments for melanoma. However, in many cases, tumors eventually become resistant to the drugs and cause a relapse in [..]

  • FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

    Share Now1sharesFacebook1Twitter0Google+Pinterest0FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) By: Catalyst Pharmaceuticals, Inc. NEWS Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved [..]

  • Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease

    Share Now1sharesFacebook1Twitter0Google+Pinterest0Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease By: Novartis News Novartis announced today that the European Commission (EC) approved Luxturna, a one-time gene therapy for the treatment of patients with vision loss due to a genetic mutation in [..]

  • FDA Grants Accelerated Approval to Genentech’s Venclexta® for Acute Myeloid Leukemia

    Share Now14sharesFacebook14Twitter0Google+Pinterest0FDA Grants Accelerated Approval to Genentech’s Venclexta® for Acute Myeloid Leukemia By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Venclexta® (venetoclax), in combination with a hypomethylating agent (azacitidine or decitabine), [..]

  • Study Opens Route to Ultra-Low-Power Microchips

    Share Now1sharesFacebook1Twitter0Google+Pinterest0Study Opens Route to Ultra-Low-Power Microchips By: David L. Chandler | MIT News Office A new approach to controlling magnetism in a microchip could open the doors to memory, computing, and sensing devices that consume drastically less power than existing versions. The approach could also overcome some of the [..]

  • FDA Approves Novartis Drug Promacta® for First-line SAA |Breakthrough Therapy Designation

    Share Now2sharesFacebook2Twitter0Google+Pinterest0FDA Approves Novartis Drug Promacta® for First-line SAA |Breakthrough Therapy Designation By: Novartis News Basel, November 16, 2018 – Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta®(eltrombopag) to include first-line treatment for adults and pediatric patients two years and older with SAA [..]

  • Liquid Fuel That Can Store The Sun’s Energy For Up to 18 Years

    Share Now1sharesFacebook1Twitter0Google+Pinterest0Liquid Fuel That Can Store The Sun’s Energy For Up to 18 Years Originally Published at www.sciencealert.com  No matter how abundant or renewable, solar power has a thorn in its side. There is still no cheap and efficient long-term storage for the energy that it generates. The solar industry [..]

  • ‘Bionic Mushrooms’ Fuse Nanotech, Bacteria and Fungi

    Share Now1sharesFacebook1Twitter0Google+Pinterest0‘Bionic Mushrooms’ Fuse Nanotech, Bacteria and Fungi By:  Stevens Institute of Technology. In their latest feat of engineering, researchers at Stevens Institute of Technology have taken an ordinary white button mushroom from a grocery store and made it bionic, supercharging it with 3D-printed clusters of cyanobacteria that generate electricity and [..]

  • Graphene Takes a Step Towards Renewable Fuel

    Share Now1sharesFacebook1Twitter0Google+Pinterest0Graphene Takes a Step Towards Renewable Fuel By: Linköping University Researchers at Linköping University, Sweden, are working to develop a method to convert water and carbon dioxide to the renewable energy of the future, using the energy from the sun and graphene applied to the surface of cubic silicon carbide. [..]

  • Detecting E. coli Strains Using Molecular Electronics

    Share Now4sharesFacebook4Twitter0Google+Pinterest0Detecting E. coli Strains Using Molecular Electronics By: University of California – Davis News Finding a fast and inexpensive way to detect specific strains of bacteria and viruses is critical to food safety, water quality, environmental protection and human health. However, current methods for detecting illness-causing strains of bacteria [..]

  • TWIICE One Exoskeleton is a Step Towards Independence

    Share Now1sharesFacebook1Twitter0Google+Pinterest0TWIICE One Exoskeleton is a Step Towards Independence By: Anne-Muriel Brouet The new version of the TWIICE walking-assistance system is not only lighter, more comfortable and more powerful, but patients can also put it on and use it themselves – giving them greater independence. It has been tested by handcycling [..]